[Aspects of the therapeutic action of proteolytic enzymes and antibiotics in experimental staphylococcal infection. The effect of lincomycin, chymotrypsin and their combinations on leukocyte phagocytic activity].
The effect of leucomycin, chimotrypsin and their combination on the leucocyte phagocytic activity was studied on mice with experimental staphylococcal infection. Lincomycin and chimotrypsin were administered in doses of 150 and 2 mg/kg respectively. In the study of the leucocyte phagocytic activity it was found on the 3rd, 7th, 14th and 21st days after the beginning of the animal infection and treatment that the experimental staphylococcal infection stimulated the non-specific phagocytosis. Lincomycin inhibited the leucocyte phagocytic activity. The use of chimotrypsin in the process of the staphylococcal infection treatment resulted in increased phagocytosis activity. The combined use of chimotrypsin and leucomycin decreased the inhibitory effect of the latter on phagocytosis.
D000818:Animals; D002918:Chymotrypsin / Q000627:therapeutic use*; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D007962:Leukocytes / Q000187:drug effects*; D008034:Lincomycin / Q000627:therapeutic use*; D051379:Mice; D010587:Phagocytosis / Q000187:drug effects*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013997:Time Factors
D004338:Drug Combinations; D008034:Lincomycin; D002918:Chymotrypsin
O nekotorykh aspektakh lechebnogo deĭstviia proteoliticheskikh fermentov i antibiotikov pri éksperimental'noĭ stafilokokkovoĭ infektsii. Vliianie linkomitsina, khimotripsina i ikh sochetaniĭ na fagitsitarnuiu aktivnost' leĭkotsitov.